Skip to content
To boost or not to boost – Part 2 episode artwork

Sep 15, 2022 11 min

To boost or not to boost – Part 2

from Modern Practice Podcast Hosted by Dr. Tom Villanueva and Vizient Medical Leadership Team

This episode continues our discussion on the new bivalent COVID boosters that target the original virus and also Omicron subvariants BA.4 and BA.5. Guest speaker: Azra Behlim, PharmD, MBA Associate Vice President, Pharmacy Sourcing and Program Services Vizient Moderator: Tomas Villanueva, DO, MBA, FACPE, SFHM Senior Principal, Clinical Operations and Quality Vizient Show Notes: [00:30] Is the booster safe? [00:48] Efficacy [01:32] How long to wait after previous vaccine [02:47] Whether or not to get flu vaccines [05:58] Feasibility of using the booster as an initial vaccine in a series [07:52] Novavax [09:05] Nasal vaccines and mucosal immunity Links | Resources: To contact Modern Practice: [email protected] FDA announcement on new vaccine boosters (8-31-22): Click here Subscribe Today! Apple Podcasts Amazon Podcasts Android Google Podcasts Spotify Stitcher RSS Feed

Episode details come from the podcast's RSS feed.

Embed this episode

Ready to play

To boost or not to boost – Part 2

0:00 11:03

No transcript yet.

Requests help us decide what to transcribe next.

Frequently asked questions

How long is this episode of Modern Practice Podcast?

This episode is 11 minutes long.

When was this Modern Practice Podcast episode published?

This episode was published on September 15, 2022.

Can I download this Modern Practice Podcast episode?

Yes. Use the download control on the episode player to save the publisher-provided media file.